Nuclear receptor coregulators such as steroid receptor coactivator-1 (SRC-1), transcription intermediary factor 2 (TIF2) and the NR corepressor (N-CoR) have been shown to play a role in breast cancer tumor progression [55]. This evidence concerns the gene NCOA2 and breast carcinoma.